SH3BP1 and chronic myelogenous leukemia, BCR-ABL1 positive: Likewise, the identical SH3 motif of PACSIN2 binds to the proline‐rich domains of SH3BP1, and SH3BP1 overexpression decreases the susceptibility of CML to nilotinib similar to the function of Cobll1.